Winslow Evans & Crocker’s Vivani Medical VANI Stock Holding History

Winslow Evans & Crocker’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-195	Closed	-$1K	–	1159
2020 Q2	$1K	Hold	195	–	–	﹤0.01%	1108
2020 Q1	$2K	Hold	195	–	–	﹤0.01%	1070
2019 Q4	$4K	Hold	195	–	–	﹤0.01%	1033
2019 Q3	$4K	Buy	195 +150	+333%	+$2.96K	﹤0.01%	1026
2019 Q2	$2K	Hold	45	–	–	﹤0.01%	1106
2019 Q1	$2K	Buy	45 +21	+88%	+$409	﹤0.01%	1261
2018 Q4	$2K	Hold	24	–	–	﹤0.01%	1057
2018 Q3	$2K	Hold	24	–	–	﹤0.01%	1070
2018 Q2	$2K	Buy	+24	New	+$1.04K	﹤0.01%	1081

Other funds holding VANI

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BRWM

B. Riley Wealth Management Memphis, Tennessee $85.5M AUM 3.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return

Winslow Evans & Crocker's VANI Position: Q3 2020 in Review

Winslow Evans & Crocker sold out of Vivani Medical (VANI) in Q3 2020, closing a stake of 195 shares — an estimated $1K sold.

Winslow Evans & Crocker first reported a position in VANI in Q2 2018 and held it in 9 quarters. The position peaked at $4K in Q4 2019. 20 funds tracked by Wall St. Rank hold VANI as of Q3 2020.

Winslow Evans & Crocker reported no remaining Vivani Medical position as of Q3 2020 after selling out during the quarter.
Winslow Evans & Crocker sold 195 Vivani Medical shares in Q3 2020, an estimated $1K.
Winslow Evans & Crocker first reported a position in Vivani Medical in Q2 2018 and held it in 9 quarters.
Winslow Evans & Crocker's Vivani Medical position peaked at $4K in Q4 2019.
20 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2020.

Based on Winslow Evans & Crocker's 13F filing for Q3 2020, filed 21 Oct 2020.